Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Ltd GNTLF

Healthcare Medical Care
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk... see more

Recent & Breaking News (OTCPK:GNTLF)

Genetic Technologies Transitions to Online Commercial Platform for BREVAGenplus®

GlobeNewswire September 21, 2017

Genetic Technologies Announces Comprehensive Review of Strategic Alternatives

Marketwired August 25, 2017

Genetic Technologies Launches Breast Cancer Awareness Month Promotion for BREVAGenplus(R)

Marketwired August 1, 2017

Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017

Marketwired July 27, 2017

Genetic Technologies Receives Nasdaq Deficiency Notice

Marketwired July 21, 2017

Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplus(R)

Marketwired March 31, 2017

Genetic Technologies and IndyCar's Pippa Mann Partner for Second Consecutive Year to Promote BREVAGenplus(R)

Marketwired March 29, 2017

Research Reports Coverage on Biotech Stocks -- Genetic Technologies, Alder Biopharma, BioDelivery Sciences, and Egalet

PR Newswire January 24, 2017

Genetic Technologies Announces Offering of USD 6.0 Million of American Depository Shares

Marketwired December 1, 2016

Biotech Sector Growth Expected Upon Diminishing Concerns Over Drug Pricing

PR Newswire December 1, 2016

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  November 29, 2016

Mid-Day Market Update: U.S. Stocks Turn Higher; Nivalis Therapeutics Shares Tumble After Failed Drug Trial

Benzinga.com  November 29, 2016

Mid-Morning Market Update: Markets Edge Lower; Tiffany Tops Q3 Expectations

Benzinga.com  November 29, 2016

Genetic Technologies Limited and The University of Melbourne Enter into Exclusive Worldwide License Agreement to Develop Colorectal Cancer Risk Assessment Test

Marketwired November 29, 2016

Genetic Technologies Launches BREVAGenplus(R) Marketing Program Around Susan G. Komen(R)'s Race for the Cure(R) Events

Marketwired October 3, 2016

Genetic Technologies Limited (Nasdaq: GENE) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire May 5, 2016

Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann to Ring Nasdaq Stock Market Closing Bell on May 6th, 2016

Marketwired May 4, 2016

Four Trending Stocks That Require Your Attention on April 15th

ACCESS Newswire April 15, 2016

Genetic Technologies and IndyCar's Pippa Mann Announce Partnership to Promote BREVAGenplus(R)

Marketwired February 22, 2016

Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of BREVAGenplus(R)

Marketwired December 21, 2015